Ladies and gentlemen, thank you for standing by, and welcome to the Nutanix Q1 fiscal year 2021 earnings conference call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one on your telephone. Please be advised that today's conference is being recorded, and if you require any further assistance, please press star zero. Now I would like to hand the conference over to your speaker today, Ms. Tonya. Please go ahead.
Good afternoon, and welcome to today's conference call to discuss the results of our first quarter of fiscal 2021. This call is also being broadcast over the web and can be accessed in our investor relations website at ir.nutanix.com. Joining me today are Dheeraj Pandey, Nutanix's CEO, and Duston Williams, Nutanix's CFO. After the market closed today, Nutanix issued a press release announcing financial results for its first quarter of fiscal year 2021. If you'd like to read the release, please visit the press releases section of our IR website.
During today's call, management will make forward-looking statements, including statements regarding our business plans, strategies, and outlook, including our financial performance, use of financial targets and performance metrics, and competitive position in future periods, the timing and impact of our current and future business model transitions, the factors driving our growth, the timing and impact of our announced CEO transition plan, and the current and anticipated impact of the COVID-19 pandemic. These forward-looking statements involve risks and uncertainties, some of which are beyond our control, which could cause actual results to differ materially and adversely from those anticipated by these statements. For a detailed description of these factors, please refer to our SEC filings, including our most recent annual report on Form 10-K for fiscal 2020, filed with the SEC on September 23rd, 2020, as well as our earnings press release issued today.
These forward-looking statements apply as of today, and we undertake no obligation to update these statements after this call. As a result, you should not rely on them as representing our views in the future. Please note, unless otherwise specifically referenced, all financial measures we use on today's call are expressed on a non-GAAP basis and have been adjusted to exclude certain charges. We have provided, to the extent available, reconciliations to these non-GAAP financial measures to GAAP financial measures on our IR website and in our earnings press release. Lastly, Nutanix management will host virtual meetings with investors at the Credit Suisse 24th Annual Technology Conference on December 1st, the Wells Fargo TMT Summit on December 2nd, the Raymond James Technology Conference on December 7th, and the Needham Growth Conference on January 11th. We hope to connect with many of you there.
With that, I'll turn the call over to Dheeraj. Dheeraj?
Thank you, Tonya, and good afternoon, everyone. Q1 was a very good quarter, positioning us well for the rest of fiscal 2021. While Duston will go into more details on the financials, the headline is that we outperformed across all our key metrics. ACV billings were 14% ahead of the midpoint of our guidance and consensus, and notably, Q1 was our best ACV bookings quarter ever, the pandemic notwithstanding. In addition, we delivered strong gross margins, EPS, and free cash flow performance. We are delighted with our continued progress, and it is great to look back on our journey over the last three years and see how far we have come. Our product thesis of a hybrid and multi-cloud future built on top of our industry-leading Hyper-Converged Infrastructure, the HCI of last decade, combined with an ambitious transition to a cloud-like subscription business model, is bearing fruit.
While there's more to do, so the hardest work is behind us, and I'm proud and grateful for what we've collectively accomplished to date. There were a number of factors that contributed to our Q1 performance. First, our ACV-based sales compensation strategy delivered positive benefits to our business. In Q1, our average contract term shortened, and as a result of the shift, we saw lower overall discounting, and we sold more new products, all while driving significant run rate ACV growth of 29% year-over-year at a $1.3 billion scale. As I mentioned, we saw strong adoption of our new products on top of growth in our core software. On a rolling four-quarter basis, our new product attach rate during Q1 was 35%, up 7 percentage points from a year ago. In fact, new ACV for new products grew 87% year-over-year and 27% quarter-over-quarter.
Within our newer products, we saw particularly good momentum with our data center solutions, Files and Flow, as well as DevOps and Database-as-a-Service solution, our Calm and Era. Notably, a significant number of new product deals also included more licenses for our core software, proving our thesis that as we drive demand for our new products, we also drive demand for our core software, which is the foundation for our hybrid cloud infrastructure, the new HCI of this decade. Demand for our solutions was consistent across all our geographies and many verticals, including Federal, which had a good quarter as expected, owing to the seasonality of the U.S. government's fiscal year-end. The Federal sector also had a number of one-year contract duration deals contributing to the reduction of average contract durations in the quarter, which Duston will address in more detail.
As always, our customer journey is the best way to speak of the quarter. A customer win during the quarter that combined many of the themes I've discussed was with one of the largest and oldest financial services firms in the world, providing investment management, servicing, and administration. This existing customer, which has spent more than $20 million in lifetime, spent another $1.7 million in ACV to expand their private cloud. We also had a very similar story with one of the largest power companies in Japan, which has spent upwards of $15 million lifetime digitizing their desktops and filers with our software stack, spending another $1.8 million in ACV in Q1. Our strong results were also driven by our go-to-market momentum in the era of cloud, specifically the successful launch of our ACV sales compensation plan, together with effective sales enablement and training around ACV benefits.
In addition, our sales teams have done an excellent job of improving the quality of the sales process by building a robust pipeline, even during COVID-19, working closely with partners and adopting a multi-product and multi-workload sales approach. The channel continues to play an extremely important role in how we help evolve our customer journey. To that end, we announced a simplified channel program to deliver even more profitability and an accelerated roadmap to help partners embrace the cloud business model. Additionally, we made meaningful improvements to Nutanix University, our education arm. The program now provides more certifications across new skill levels and technology stacks to increase the stickiness of Nutanix software and overall consumption of our technology. We quadrupled participation in this program in the past year, with over 30,000 learners and counting.
Our on-prem partnerships with HPE, Dell, Lenovo, and others continue to be an important part of our strategy for offering freedom of choice to our customers. In fact, we had our best quarter to date with HPE in new ACV, as well as meaningful new customer acquisition. A great example of a new customer we gained during this quarter is a large European furniture retailer who selected our core software, Database-as-a-Service solution, Era, and automation software, Calm. They plan to implement a fully automated distributed cloud solution that will reduce IT implementation time from weeks to days with no IT staff on-site, especially as they navigate the pandemic. Speaking of the pandemic and the digital transformation it has helped accelerate, for the past several quarters, we have become a meaningfully digital marketing organization.
Test Drive, our zero-touch self-service for prospects, continues to provide distinctive top-of-the-funnel engagement and has been shown to shorten sales cycles while delivering the highest conversion rate of all of our marketing programs. We also continue to hold virtual events globally, and in Q1, we held our largest event ever, virtual or in person, in our company history. Our 100% virtual .NEXT event had record attendance of over 40,000 prospects, customers, and partners, and is on track to deliver strong pipeline generation in the quarter at a significantly lower cost than in-person events. Let me also share with you how we are morphing from being a pioneer in on-prem hyper-converged infrastructure to being an authentic hybrid cloud infrastructure, the new HCI company. During the quarter, we announced the general availability of Clusters, our HCI on AWS.
We also announced a significant partnership with Microsoft to bring our product portfolio onto Azure. This partnership substantially evolves our company strategy, enabling us to provide solutions that will deliver seamless application, data, and license mobility, including a singular experience of management across all clouds. This is a major competitive advantage as we become the foremost infrastructure software company with a bring-your-own-license approach to help our customers in their hybrid computing journey. As we've stated in the past, the availability of Nutanix Clusters on AWS also offers new benefits, including extending the simplicity and ease of use of our software to the public cloud. This represents a significant step forward in realizing our vision to make computing invisible anywhere by delivering a unified fabric across multiple clouds, public or private.
A financial services institution in the APJ region is an example of a new customer who purchased Clusters on AWS during the quarter in a one-year contract. They selected Nutanix to help support their growing test and dev needs for services to their clients, and Nutanix Cluster on AWS provides them with the flexibility and frictionless migration to any cloud they require. Our core platform and new products in the quarter. This includes new capabilities to our core software platform, as well as the launch of our Kubernetes-based PaaS solution, Platform-as-a-Service, and significant updates to our Database-as-a-Service solution, Era. Subscription business models continue to underscore the need for consumption and renewals, our product reliability and outstanding customer service continue to be a big driver of our loyalty and repeat business.
For the 7th year in a row, we were awarded The NorthFace ScoreBoard Award from CRMI in recognition of our customer centricity. Because of our sustained excellence for having won this award for more than 5 years, we were also conferred The NorthFace Summit Class Award, which is a rare honor. Finally, as we think about our performance relative to our future opportunity, I'd like to talk briefly about our addressable markets and how they continue to grow and evolve. Gartner predicts that by 2025, 80% of organizations will be using hyperconverged solutions, doubling from 40% in 2020. We've been encouraged to see that IT spending has held up despite the pandemic, as companies prioritize modernization with private and public clouds, hands-free automation and remote work, and business continuity projects.
This is validated by the results for our third annual Nutanix Enterprise Cloud Index, which we launched last week. Across the pandemic, global IT teams are planning substantial infrastructure changes and collectively see hybrid cloud deployments increasing 37 percentage points over the next five years. In short, these trends provide a powerful tailwind in the lift and shift to cloud, both private and public. With that, let me hand it over to Duston. Duston?
Thank you, Dheeraj. Going into the quarter, we provided guidance that took into consideration both an uncertain macro environment and our transition to an ACV-based sales compensation model. We clearly outperformed our expectations and are very pleased with the strong start to the fiscal year. As we entered FY 2021, our overall thesis for the business going forward is centered on the following. Our industry-leading product set that seamlessly enables on-prem, off-prem, and the convergence of both remains the best and most elegant solution in the marketplace. New products will continue to drive the growth of our core HCI offering by further extending our solution to address new opportunities that were previously out of reach with our core solution alone.
Optionality truly matters to our customers and prospects, offering subscription options with variable terms and their corresponding flexibility will continue to add significant optionality, which in turn leads to additional ACV growth. Our ACV first focus will ultimately strengthen our business model via term compression, leading to lower discounting, better deal economics, accelerated ACV growth, and a shorter time to more efficient renewals. Finally, we expect our go-to-market execution will continue to show improvement, and this, combined with a market-leading solution, ultimately becomes a very powerful combination for ACV growth going forward. The business thesis set forth above clearly played out in Q1. During the quarter, our core product continued to perform very well, with new customer ACV bookings representing 23% of total ACV bookings, ex renewals. We also added about 680 net new customers in the quarter, despite the ongoing macro uncertainties related to COVID.
Linearity was also very good during Q1. We generated a record amount of new pipeline, and we also added a substantial amount of ACV backlog compared to a typical usage of backlog in previous Q1s. As you may recall, during our Q4 earnings call, it was our belief that our ACV-based sales comp would put a renewed focus on new product sales. Not surprisingly, new products performed very well in Q1. As Dheeraj noted, we had a record quarter of new ACV related to our new products, with Calm, Era, Files, Flow, and Objects all delivering record ACV quarters. New products also played a role in improving our deal economics during the quarter. Furthermore, the benefit of subscription optionality clearly came into play during the quarter, with more customers opting for the budget flexibility of one-year deals.
Our outperformance on one-year deals in Q1 has added an incremental $20 million-$25 million to the renewals pool that will come up in Q1 FY 2022, which is over and above our previous plan. We expect these renewals to be more predictable and transacted at significantly less cost compared to our new and upsell business, which will drive leverage in our model. As we look ahead, we are very optimistic about the setup for the balance of the fiscal year. In Q1, we experienced lower discounting that resulted in better deal economics, as well as some term compression, all as we expected. The specifics around the actual Q1 term compression also mirrored our previously communicated expectations. Specifically, that our new ACV-based sales comp plan would compress terms, and we would see a shift from five-year deals to more three-year and one-year deals.
When terms did compress, existing customers would not experience any significant term compression, while new customers would potentially see larger amounts of term compression. In Q1, average contract term decreased to 3.5 years compared to 3.8 years in Q4 2020, which was somewhat lower than our expectations. Federal completed several large one-year deals, which contributed to the average decrease. Since our federal business is usually a much smaller percentage of our total business in Q2 versus Q1, we do not expect the federal business to have the same level of impact on average term in Q2. While we did not plan to disclose this level of detail every quarter, average contract term of existing customers, ex renewals, decreased by 1/10 of a year, while average contract term of new customers declined by six-tenths of a year.
Lastly, our go-to-market is showing consistent execution, as evidenced by our top-line outperformance over the last few quarters. Although we only have one quarter under our belt in FY 2021, we are very encouraged with our progress to date. Now I'll move on to some specific Q1 financial highlights. ACV billings were $138 million, reflecting 10% growth year-over-year, well above our guidance range of $118 million-$121 million. Run rate ACV as of the end of Q1 was $1.29 billion, growing 29% year-over-year compared to our guidance of at least 20% growth. Revenue, which as expected, was impacted by decreased average term length, was $313 million, down 1% year-over-year. Our non-GAAP gross margin in Q1 was 81.9% versus our guidance of 81%. Operating expenses were $341 million, down 12% year-over-year and versus our guidance of $350 million-$360 million.
End user computing as a percent of total business was flat versus Q4 2020 as the spike in demand we saw at the beginning of COVID-19 moderated. During the quarter, we completed our previously announced $125 million stock buyback. We purchased 5.175 million shares at an average price of $24.15 per share. As a reminder, the stock buyback was executed with the intention of offsetting the additional dilution that we will incur related to the PIK, or paid in kind, interest feature on the Bain convertible notes. Our non-GAAP net loss was $89 million for the quarter, or a loss of $0.44 per share. Our free cash flow for Q1, which was aided by very good linearity, was negative $16 million. This performance was significantly better than our internal expectations. We closed the quarter with cash and short-term investments of $1.32 billion versus $720 million in Q4 2020.
The Q1 cash total includes $750 million from the Bain convertible note, less expenses and $125 million stock buyback. DSOs in Q1 were 54 days versus 68 days in Q4 2020, also driven by good linearity. Turning to our Q2 2021 guidance. ACV billings to be between $145 million and $148 million, representing year-over-year growth of 4% to 6%. Gross margin of approximately 81.5%. Operating expenses between $360 million and $370 million, representing year-over-year decline of 7%- 9%. Weighted average shares outstanding of approximately 202 million. A few modeling assumptions. Our guidance for Q2 includes a slightly negative COVID impact as we continue to be cautious in the light of the second and third waves of COVID that could create additional macro uncertainty.
On a bookings basis, the implied year-over-year growth rate over our Q2 2021 ACV is expected to be substantially higher as we consume the backlog in Q2 2020. As a reminder, similar to what we have experienced over the last two years, we would expect Q3 to exhibit sequential seasonality, which suggests a slight decrease in ACV billings in Q3 versus Q2. Based on the Q2 2021 ACV billings guidance, we would expect run rate ACV to continue its strong growth trend and grow approximately 25% year-over-year. We are projecting a slight decrease in term lengths in Q2 compared to 3.5 years in Q1. From a free cash flow perspective, we are not currently expecting Q2 linearity to mirror that of Q1, and therefore, we expect our cash usage to increase in Q2.
Regardless of the exact amount of cash usage in Q2, we would expect free cash flow for the first half of FY 2021 to exceed our internal plan set forth at the beginning of the fiscal year. While we maintain our focus on go-to-market efficiencies and we continue to benefit from lower travel costs, as we have previously communicated, we anticipate fiscal 2021 operating expenses to be flat to slightly higher than last year as we continue to grow and invest in the business. Finally, as we did last quarter, to help with your modeling, included in our earnings presentation located on our ir.nutanix.com, are historical trends for ACV billings, run rate ACV, billings term length, and a bridge on how to model and convert our current and future ACV billings guidance to total billings.
With that, I'd like to pass it back to Dheeraj for additional remarks before we take questions. Thank you.
Thanks, Duston. I wanted to close this quarter's earnings call with a thank you to everyone who has participated in the journey to get where we are now. We are extremely encouraged with the progress of the last three years of our business model transformation. While we still have work to do, these results demonstrate the power of the subscription thesis. Our board continues to make progress on the CEO search. We look forward to updating you when we have meaningful news. Personally, it has been a journey of a lifetime to serve our customers and partners, working alongside Nutants, as we call our employees. With a future-proof business model, a customer base that fundamentally values reliability, and a technology portfolio that has such a strong product market fit, our best is yet to come.
This is the decade to watch for a company that so values simple, secure, and seamless. Now, we'll open it up for questions.
At this time, as a reminder, to ask a question, you will need to press star one on your telephone. To withdraw your question, press the pound key. We do ask that participants limit themselves to one question and one follow-up. However, please feel free to queue up again if you have any additional questions. Your first question will come from the line of Jason Ader of William Blair. Please go ahead.
Yeah, thanks. Hey, guys. My question is on the ACV transition, and it seems like maybe there were a little bit of surprises, but if you could just talk about, broadly speaking, what surprised you, what didn't surprise you, and why you did better than you expected?
Yeah, I'll take a shot. Dheeraj, feel free to jump in here, too.
Yeah.
Jason, I would say there was very few, if any, real surprises. I think, which we talked about, we had an opinion and view going into Q1, and pretty much all those views played out as planned. We thought terms would decrease. We thought they'd decrease more in new customers, less on existing customers. We thought that that would lead to higher deal economics. Deal economics improved. Optionality we knew mattered, and it mattered not only for our customers but for our sales reps, because they have more tools now to offer as they go attack their quotas. I can't really think of anything. It was maybe a tenth lower or so on the terms than we expected, but that's not an exact science anyway. There was just very little surprises that we hadn't thought through, quite honestly.
I think the ACV, certainly from a sales comp, I think played out better than probably we anticipated, and I think everybody has rallied around that. Optionality, again, matters, and you saw what it delivered for a quarter and a good guide for Q2.
The demand environment.
Yeah.
Better than you expected?
Well, based on record pipeline, we were pretty pleased, especially in this environment. It's not perfect and the economy is not humming at full 100%. There's still verticals that are very impacted here. Yeah, I think we were pretty pleased overall from that perspective, too.
Yeah, I think the only thing I'll add to that, Jason and Duston, is how very much like Federal was for us early on in 2011- 2015, I think the Federal business with ACV has really embraced this. We kind of knew it when we were going into it, that O&M is going to be our friend, because a lot of Federal spend is operations and maintenance, where they keep it under the radar in terms of spend and budgeting. It turned out to be a great quarter for Federal. Part of it is because of the one-year deals that Duston talked about. Maybe the other pleasant surprise has been how our salespeople have embraced it, to really think that this makes them a lot more competitive than selling three, five, seven-year deals.
Thank you.
Your next question will come from the line of Ittai Kidron of Oppenheimer. Please go ahead.
Thanks. Hey, guys. Nice quarter. A couple of questions from me. First of all, from a sales force capacity, how do you guys think about the evolution of the capacity going forward, just given that renewal activity in O&M is now going to be done on an annual basis instead of a multi-year basis, so more time from a sales capacity standpoint will be dedicated to renewals than getting new business. How do you think about the evolution of capacity? Does that mean you need to
hire aggressively again on that front in order to create more new customer capacity.
So-
Yeah, and that-
Should I take this, Duston?
Sure. Go ahead, Dheeraj.
I think the field reps are all focused on land and expand, which is all new ACV-focused. Now, they will get a ding if they didn't get the renewal. All in all, we expect them to be really focused on land and expand. While there's a customer success team, which is all on the inside, on the phone, that's really doing adopt and renew, and that's how they're going to be comped as well.
Got it. Yeah, no, what I'd add to that, Ittai, is that the whole thesis around this, one of the main premise here around the move to ACV is leverage, right? That's the exact point. All the renewals will not take aggressive hiring, right? Because that's going to be handled predominantly by a separate team. Now we have to go build up that separate team. All these renewal impact from just the acceleration of one-year deals in the quarter. We've added $20 million-$25 million to the pool in Q1 2022, and that's not going to require new reps to go attack that. That's the premise of the ACV move.
Got it. Okay. Maybe as a follow-up, maybe just then on that topic, clearly you've done very well in cutting the contract term quite aggressively in the quarter.
I guess it was just a little bit outperformance there. Does this help you, make you perhaps think differently about where is your long-term steady state from a term standpoint or the pace by which you can get there?
Not dramatically. Federal played a role in some of the term compression in Q1. They won't be the same percentage of the business in Q2, so there's some offsetting factors there. We've got this view of kind of low three-year average somewhere at the end of the fiscal year. We'll see how that plays out. I think the more that our sales reps get used to this model, and maybe to a certain degree, the more our customers get used to this model, with the optionality and things like that, maybe we see a little bit bigger push.
One quarter is too early to give a real opinionated view, especially because how Federal kind of played into this a little bit. Certainly, we're encouraged from what we've seen from the first quarter anyway.
There's going to be opposing forces as well. The large enterprises in places like Japan, they're probably still going to be longer term. Some of our very large customers are still longer term. You look at federal and commercial on the other side, that will go shorter term. I think it's going to be a healthy yin yang between these two.
Our next question will come from the line of Alex Kurtz of KeyBanc. Please go ahead.
Thanks. I had a question, but I want to start with a clarification. Duston, on the contract duration target, that three, this throughout, was that the end of fiscal 2022 you were targeting?
Again, we've got one quarter, but what I was referencing there, kind of in the low threes at the end of fiscal 2021.
Do you think there's a chance that given what you saw with the one-year opportunities that this thing could dip below three at some point in fiscal 2022, or too early to tell?
It's too early to tell. As Dheeraj said, you've got some older school customers that still will hang and cling to five-year deals too. I think, again, one quarter is just too early to tell. We're encouraged of everything that we thought was going to happen pretty much happened. Give us another quarter and we'll give another, I think, better opinion.
My question is for Dheeraj.
I just want to say that we'll be able to go and tweak this depending on how much cash we need to collect as well, based on simple sales incentives and such as well as part of sales compensation. We're not overly worried. We feel like now we have a great architecture in place, and we can go and tweak the way we want it.
Dheeraj, I appreciate that. Dheeraj, a question to you about the person to replace you when that decision happens. I've been in a lot of discussions with investors about what the right profile would look like and capabilities and experience. Now that you're a little bit into this process, maybe you could share your vision about the person that would take over your role as CEO, and what you would like to see that person bring to the table. I know you touched on it a little bit last quarter. If you could expand, I think that would be very helpful.
I think the big piece is how do you balance the short term and the long term? Because you can't overdo one or the other. You have to be strategy-focused, be able to look around the corner, because computing is an industry that's changing so fast that you can't take your eyes off the strategy ball. Basically, someone who can embrace process, people, technology, and product. I think we've gotten some great candidates in the pipeline, and we definitely would like the relevance of infrastructure to be there. There's a lot of people out there in the business software space. We're looking at quite a few people in infrastructure as well. I think all in all, somebody who has a three-to-five-year view and a vision would be very important, especially for our sales engineers, our developers, our system reliability engineers.
There's a lot of engineering in the company in various different departments that also need to look up to somebody for strategy and the public cloud landscape that's out in front of us.
Our next question will come from the line of Jack Andrews of Needham. Please go ahead.
Good afternoon. Congratulations on a good start to the new fiscal year. I wanted to see if you could drill down a bit more on the new product strength that you're experiencing. You mentioned a number of products that you're seeing success with. Could you drill down on the specific types of use cases? Are they mainly DevOps related, or something else? The related question is, have you changed any sales incentives around new products, or do you credit the shift to ACV as helping to drive this new product attach rate?
Duston, do you want me to take that or should you take it?
I'll let you take the use cases, Dheeraj.
Okay. Cool. Yeah. First of all, we saw really good unit economics, as Duston said, because of short new term lengths. We're not taking money out of one pocket and putting it in the other. We are very mindful of that. New products have to fend for themselves, and they have to pull through the core. A lot of what we hawkishly watch for is no financial engineering of money moving from the core business to new products. I think all in all, we saw some great traction in Database-as-a-Service. Again, amazingly good economics with large databases, Oracle, SQL, SAP, Epic in healthcare. We're seeing a ton of large database workloads, and we've made them so simple that DBAs are loving this new architecture, and the fact that they can drag and drop it from one cloud to another.
The other one is around unstructured data, files, and objects, especially with containers. We're doing a really good job around that DevOps use case. Finally, desktop as a service. I think there's a lot of work we've done, not just for Citrix and VMware Horizon, but also around our own brokers. All in all, I think databases, unstructured data, and desktop as a service. I've seen some great use cases around that. Duston?
Then just on the sales comp part. For the most part, some things spread around, but for the most part, I believe it was certainly helped by the move to ACV, because you got to remember, now a $100,000 one-year deal for a new product is the same as a $500,000 deal that they had to go try to do on a five-year basis. There's clearly more optionality, not only on our customers' perspective, but with the sales reps to go use these different tools from an ACV perspective and go drive additional quota retirement with smaller terms. I will say this played well. There's obvious little things here and there, but it played well in all regions. All regions were above quota, which we love to see, obviously. That kind of gives you a little bit of feel of the power of optionality.
Great. I appreciate the color. Thank you.
Our next question will come from the lines of James Fish of Piper Sandler. Please go ahead.
Hey, guys. Thanks for the question. Just want to drill down on the change to ACV-based compensation. Can you give us further color as to what you're seeing from reps and whether this caused any additional churn than normal as your employee count and your sales and marketing count actually was down sequentially?
I'm sorry. On the last part of the question was what again?
Just your sales and marketing and total employee count was down sequentially. I'm just wondering, on the change to ACV-based compensation, can you give us further color as to what you're seeing from reps and if it caused additional churn in the quarter than normal?
Oh, yeah. Churn in general within the sales organization isn't much different from what it has been over the last several quarters now. There might have been some more selective and maybe some forced churn, to focus maybe on a little bit more software selling and things like that. Overall, the churn rates aren't significantly different now. What Chris Kaddaras and team have done, though, in the field is they've certainly shifted to incremental leverage. How do we get more productivity out of the same reps? There's been some realignment with resources amongst regions and things like that. That's the real focus right now is that we have a reasonable amount of reps. How do you get them even more productive? Certainly from an ACV perspective and things like that. That's the main focus right now. We won't add a significant amount of reps this fiscal year.
Got it. Most of my questions have been asked, I'll cede back the time. Thank you, guys.
Our next question will come from Matthew Hedberg of RBC. Please go ahead.
Hey, it's Dan Bergstrom for Matt Hedberg. Thanks for taking our questions. Dheeraj mentioned Nutanix Clusters in the prepared remarks. Just curious around early use case for early adopters there. Are customers looking for that elasticity on-demand bursting mobility across clouds or optionality around the operating model? Just any thoughts around early adoption or what you're hearing from customers?
Absolutely. I just want to have everybody probably also draw from the whole movement of virtualization 15 years ago. A lot of the enterprises are moving from Unix servers to Intel x86, and virtualization had to find a great use case, and that was test and dev, and then it became VDI. At five years, Citrix was one of the biggest workloads for VMware, apart from test and dev in 2008 and 2009. For us, I think we are, again, very use case-focused when it comes to clusters. It's a very important piece of the puzzle is around very high IO-intensive workloads, low latency workloads, test and dev virtual desktops, and also lift and shift. I think there's a big disaster recovery sort of initiative coming within the large enterprises as well.
The best part about clusters is bring your own license, bring your own contract of AWS, and will be the same for Azure as well. We expect that many of these early use cases around large databases, test and dev, as you saw from one of the wins I talked about, and finally, a lift and shift to the cloud.
Great. Thanks. Maybe for Duston on the expense side, you provided some color around guidance for the quarter, for the year. From here, should we think about maybe remaining prudent on the expenses for now, but would there be a potential to maybe accelerate investment into accelerated growth? Should we start to see that on the top line further out?
Duston, are you there?
I'm so sorry.
Yeah.
In the near to midterm, hopefully, from a top-line perspective, we're going to get most of that through leverage increased rep productivity. You won't see some great hiring surge to get incremental ACV growth. We should be able to get a reasonable amount of incremental ACV growth with most of the resources we have currently. We need to continue to hire here and there, wherever. Clearly, I wouldn't put it as a surge of anything like that. We've got a fair amount of resources spread throughout the regions as it is here now. At some point, there are some things that we've just benefited from, clearly, and everybody else has. Obviously, no travel, right? At some point, some travel will come back online.
Even when whatever normal is in the future, hopefully, we won't spend nearly as much travel as we have in the past, just because everybody's learned how to do things differently. First and foremost, it's leverage, rep productivity, and then selective hiring as we need, realignment of resources as we need, and to make sure, obviously, we're taking care of customers with products and support, things like that. That's kind of the view here over the near to midterm.
Your next question will come from the line of Katy Huberty of Morgan Stanley. Please go ahead.
Thank you. Just coming off the strong October quarter ACV performance, why would ACV billings growth decelerate in January, especially given what you said about the record pipeline levels, the fact that you didn't eat into backlog like you typically do in the first quarter, and the successful .NEXT conference? Just some color as to why the outlook's a bit more conservative than the performance you just put in. I have a follow-up.
Again, we mentioned that we haven't gotten real aggressive with the Q2 outlook. We're concerned what's happening. Things are going in the wrong direction from a COVID perspective, and shutdowns, and 2nd and 3rd phases. That's clearly encompassed in our billings. To your point, we grew ACV billings 10% in Q1 year-over-year. We guided four to six. Again, though, if you look at it on a bookings basis, which we're not disclosing anymore, that 4%-6% growth rate is probably at least 2x higher on a comparative bookings basis. There's some pretty good growth when you look at it on a bookings basis, because again, in Q2 2020, we actually used some backlog, which was a little unusual from that perspective.
I think the combination of on a bookings, it's quite a bit better, and again, we've got something baked in there from a COVID perspective to a certain degree.
Just a follow-up on that last point.
Yeah.
I was just going to say, are you seeing anything in the month of November that would cause you to want to be more conservative on the outlook, or is it just the news headlines and the potential for rollback?
Yeah, news.
economic closings?
Yeah.
Okay. Got it.
News headlines. It's not much different than our prior approach. I just think at this point, I think to get very aggressive just doesn't make sense in this environment.
Yeah. Sorry, Dheeraj, didn't mean to cut you off.
No, sorry. I was just saying that, look, we had one quarter where we understand ACV and ACV-first strategy . We get a second one, we understand that'd be a coincidence. A third one would be a pattern. I think next two quarters are going to be really important for us to learn about this ACV-first strategy.
Okay. Just lastly, Duston, how do you think about, from here, the timeline to break even free cash flow? What has to happen to build confidence in that becoming a more near-term goal?
We need to get terms kind of compressed to where they're going to even out. I don't know if that's three or maybe a little bit above, maybe a little bit below. We have to have that happen first, because right now we've got two offsetting factors is how fast will terms come down. That takes out, obviously, billings and revenue. On the flip side, regardless of terms, how fast can we accelerate the ACV growth to kind of offset that? We need some stabilization in the terms first to have a good view. Now, we think that's probably the first half, maybe, of FY 2022. Then I think, the combination of some more productivity, some prudent expense growth, products, all that stuff, it sets up quite well after that point. Again, we need some stabilization.
That's why I've always been at the view that the quicker we get through the term compression, quite honestly, the better.
Our next question will come from the line of Wamsi Mohan of Bank of America. Please go ahead.
Yes, thank you. Nice quarter. Can you tell us if the renewal activity changed much during the quarter, and how we should think about renewal billings as a percent of total billings in fiscal 2021? Is 15% sort of in the ballpark there? I have a follow-up.
Yeah, we haven't given specifics on that, but the good news is we've given you now quite a bit of data to go start modeling that on your own. You now have Q4 and Q1 ACV as a percent of ACV by term length. You know now, obviously, Q1 one-year deals will flop in four quarters. You've got the three-year, the five-year, and things like that. We've disclosed quite a bit to do some pretty simple modeling from that perspective. On a TCV basis over the last 12 months, it's been roughly at 10% or below, renewals and things like that. That will start to kick up. Again, we've already added $20, $25 million to Q1 2022 just based on what happened here in this quarter, and that will continue to accelerate.
You'll see some more in 2022, and then, again, we've talked about this in FY 2023. You've got a pretty big tranche of three-year deals that start to kick in now from the initial push to subscription a few years ago.
Okay. Thanks, Duston. Can you maybe help us think about the strength between enterprise and SMB, especially given the vaccine news now, how are you thinking about sort of a recovery in SMB and maybe even just tell us where your SMB exposure is?
You want to take that, Dheeraj?
Yeah. Obviously, it's early. It's probably going to take another three quarters for administering the vaccine itself. We have a fairly international business. There are quarters in which we do about 45%-50% of our business outside the U.S. When you talk about SMB, a lot of the mid-market outside the U.S., we consider as SMB. Even the enterprise outside the U.S., we look at that as commercial. I think given the fact that we have customers in about 150 countries, we are taking a view that it will probably take two to three quarters of real administration of the vaccine itself. In the meanwhile, we are focused on new products, new workloads, and whatever we can get from new customers. I think we've done a fairly good job. We're changing a lot of our practices, like digital prospecting.
What can we do to reinvent ourselves, transform ourselves, so that when the pent-up demand opens up, we have an amazing digital business? We're doing everything we can right now to really open up for the SMB as they actually feel safer.
Our next question will come from the line of Aaron Rakers of Wells Fargo. Please go ahead.
Sorry about that. Yep. Thanks for taking the question. Congrats on the quarter. Thinking about just the modeling variables, I'm curious if you could talk a little bit about how we should think about ACV to billings ratio and how you think about billings to revenue. I'm just curious because we did see some compression on those ratios in the quarter. How do we think about those going forward? I have a follow-up.
Sure. Aaron, we've given you, I think, all the tools to go do that as far as working with ACV and TCV and doing where you think terms are going to come down. All that is pretty easily doable with the tools that we've given you there. With 0.1 of a decline or 0.2 or whatever it might be, Q1- Q2, you're not going to see massive movement, I don't think, anyway. We'll see how the quarter plays out in those ratios. On the bill to revenue ratio in general, not talking ACV, but total billings, total revenue, that's probably a little easier to talk about. With the term compression, you've got slower total revenue and total billings growth, but you still got a fair amount coming off the balance sheet, a little bit higher rate.
That's why you saw the bill-to-revenue come down this quarter. I think probably going forward for a bit, it's probably 1.1- 1.15, somewhere around there on that ratio. Again, the good news is you've got a lot of tools there to go. You can go pick where you think terms are going to be, and you can back into ACV and then total billings and all that stuff. It's a pretty easy exercise.
That's very helpful. As a quick follow-up, you mentioned in the transcript about AWS and Microsoft and the engagement there. I'm just curious, can you go a little bit deeper in terms of the go-to-market engagement with those cloud providers?
The good thing is that this bring your own contract is very helpful for consumption point of view. Both AWS and Azure sellers get paid on consumption. HCI is a killer workload to really get rapid consumption of everything that they sold as a commit. They don't get paid on commits, they get paid on consumption. We're really working hand-in-hand at Microsoft. We've actually built Nutanix Ready Nodes. It does a great job for customers as well as for the sellers. It burns the credits so that they don't lose them at the end of three years, which is what happens if you don't use the cloud credits. For the sellers, it just means that they have better, faster consumption. That's how they get paid because consumption is revenue recognition for the cloud players.
We're really working hand-in-hand with both the cloud players and their sellers and doing webinars and a lot of joint prospecting. Honestly, there's a lot that they're also understanding and learning from the enterprise because the enterprise has a lot of mundane workloads, legacy workloads. I was talking to one of the customers the other day, and they're like, "The Windows machine does not reboot in the public cloud. It does not boot up in the public cloud," because they have legacy devices and things of that nature. There's a ton of that lift and shift that will come up, and we hope to actually not have to take three years to redesign the operating system or redesign the applications before this can all come together.
Our next question will come from the line of Simon Leopold of Raymond James. Please go ahead.
Thanks for taking the question. First, what I just wanted to maybe set some context. You talked about the strong growth rates of new products, and you've rattled off some of what contributes to that, but I'm not sure I got the baseline of what percent of ACV roughly is coming from new products and how should we see that evolve over time?
We broke that out for a few quarters or a couple of points that 15% or so of new ACV is coming from new products. We've got obviously a goal in 2021 to accelerate that further. I don't think there's any reason why it shouldn't. We're off to a good start. Again, we've got all the tools to go focus on these products. We've got a continued acceleration as a percent of new ACV built into the plan.
Great. As a follow-up, and maybe somewhat related, but when we see the duration trend, one of the aspects you mentioned in your prepared remarks was the high federal contribution. I guess my understanding is some agencies are restricted to one-year term deals, so that has to play something in the mix. Could you maybe help us understand how much the federal contribution influenced the average duration and how we should think about sort of what's normal in quarters that don't have the big federal contribution? Hope that makes sense.
Yeah, it makes perfect sense. I'm not sure we have a normal yet with one quarter, obviously, but federal probably it depends how you exactly look at it with renewals or ex renewals or whatever, but a tenth, maybe you could get it to almost two tenths of a year, but let's call it closer maybe to a tenth. Federal will obviously come down as a percent of the total business here in Q2, which it always does from Q1. Then, do we get more knowledge with our sales force and more knowledge with the customer base going forward that you get some continued downward trend. That's why we assume it's a slight decrease in Q2. I'd be surprised if it was any more than that. Again, there's no normal yet. Give us another quarter, we'll give you another opinion, as I said earlier.
Again, I'd be surprised if there was any drastic movement, and again, it comes back to the new customer mix and the existing customer mix, and new will go down faster, most likely, just like we saw in Q1. Just on the new business, by the way, 680 new logos, but on a percent of ACV, new business was actually up from Q4. It was better than Q3. It was better than Q4 in, I'm sorry, in Q1. We saw some encouraging signs anyway as far as new customer ACV as a percent of total going up a little bit quarter-over-quarter too. That's just a side note there, but that's kind of the view.
With that last question, that's all the time we have left for today. This concludes today's earnings call. Thank you very much for your participation, and you may now disconnect.